1999

Carroll VA, Binder BR. The role of the plasminogen activation system in cancer.  Semin Thromb Hemost. 1999, Vol. 25(2) p183-197.

Geiger M, Binder BR. Pathophysiologie der Immobilisation. [Pathophysiology of immobilization].  Wien Med Wochenschr. 1999, Vol. 149(2-4) p33-34.

Koshelnick Y, Ehart M, Stockinger H, Binder BR. Mechanisms of signaling through urokinase receptor and the cellular response.  Thromb Haemost. 1999, Vol. 82(2), p305-311.

Bavinzski G, Richling B, Binder BR, Gruber A, Talazoglu V, Dietrich W, Schwendtenwein I, Plenk H. Histopathological findings in experimental aneurysms embolized with conventional and thrombogenic/antithrombolytic Guglielmi coils.  Minim Invasive Neurosurg. 1999, Vol. 42(4), p167-174.

Christ G, Kostner K, Zehetgruber M, Binder BR, Gulba D, Huber K. Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?  J Thromb Thrombolysis. 1999, Vol. 7(3), p277-285.

Ebel T, Gerhards J, Binder BR, Lipp J. Theileria parva 104 kDa microneme-rhoptry protein is membrane-anchored by a non-cleaved amino-terminal signal sequence for entry into the endoplasmic reticulum.  Mol Biochem Parasitol. 1999, Vol. 100(1), p19-26.

Godar S, Horejsi V, Weidle UH, Binder BR, Hansmann C, Stockinger H. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1.  Eur J Immunol. 1999, Vol. 29(3), p1004-1013.

Gottsauner-Wolf M, Sochor H, Hornykewycz S, Beckmann R, Lang I, Probst P, Binder BR, Huber K. Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients.  Thromb Haemost 1999, Vol. 81(4), p522-526.

Holzmuller H, Moll T, Hofer-Warbinek R, Mechtcheriakova D, Binder BR, Hofer E. A transcriptional repressor of the tissue factor gene in endothelial cells.  Arterioscler Thromb Vasc Biol. 1999, Vol. 19(7), p1804-1811.

Krebs M, Kaun C, Lorenz M, Haag-Weber M, Geiger M, Binder BR. Protease dependent activation of endothelial cells by peritoneal dialysis effluents.  Thromb Haemost 1999, Vol. 82(4), p1334-1341.

Krebs M, Uhrin P, Vales A, Prendes-Garcia MJ, Wojta J, Geiger M, Binder BR. Protein C inhibitor is expressed in keratinocytes of human skin.  J Invest Dermatol. 1999, Vol. 113(1), p32-37.

Mavri A, Stegnar M, Krebs M, Sentocnik JT, Geiger M, Binder BR. Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women.  Arterioscler Thromb Vasc Biol. 1999, Vol. 19(6), p1582-1587.

Mechtcheriakova D, Wlachos A, Holzmuller H, Binder BR, Hofer E. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1.  Blood, 1999, Vol. 93(11), p3811-3823.

Nikfardjam M, Graf S, Beckmann R, Hornykewycz S, Koller-Strametz J, Binder BR, Huber K. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.  Thromb Haemost. 1999, Vol. 82 Suppl 180(4) p4.

Prendes MJ, Bielek E, Zechmeister-Machhart M, Vanyek-Zavadil E, Carroll VA, Breuss J, Binder BR, Geiger M. Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytes.  Blood. 1999, Vol. 94(4), p1300-1312.

Redondo M, Watzke HH, Stucki B, Sulzer I, Biasiutti FD, Binder BR, Furlan M, Lammle B, Wuillemin WA. Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.  Arterioscler Thromb Vasc Biol. 1999, 19(4), p1020-1025.

Roller RE, Janisch S, Carroll V, Kvas E, Pilger E, Binder BR, Wojta J. Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty.  Thromb Res. 1999, Vol. 94(4), p241-247.

Seiberler S, Bugajska-Schretter A, Hufnagl P, Binder BR, Stockl J, Spitzauer S, Valent P, Valenta R. Characterization of IgE-reactive autoantigens in atopic dermatitis. 1. Subcellular distribution and tissue-specific expression.  Int Arch Allergy Immunol. 1999, Vol. 120 No.2, p108-116.

Seiberler S, Natter S, Hufnagl P, Binder BR, Valenta R. Characterization of IgE-reactive autoantigens in atopic dermatitis. 2. A pilot study on IgE versus IgG subclass response and seasonal variation of IgE autoreactivity.  Int Arch Allergy Immunol. 1999, Vol. 120 No.2, p117-125.

Sillaber C, Baghestanian M, Bevec D, Willheim M, Agis H, Kapiotis S, Fureder W, Bankl HC, Kiener HP, Speiser W, Binder BR, Lechner K, Valent P. The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis.  J Immunol. 1999, Vol. 162(2), p1032-1041.

Vrtala S, Hirtenlehner K, Susani M, Hufnagl P, Binder BR, Vangelista L, Pastore A, Sperr WR, Valent P, Ebner C, Kraft D, Valenta R. Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy.  Int Arch Allergy Immunol.1999, Vol. 118(2-4), p218-219. (only abstravt available)

Wimazal F, Sperr WR, Horny HP, Carroll V, Binder BR, Fonatsch C, Walchshofer S, Fodinger M, Schwarzinger I, Samorapoompichit P, Chott A, Dvorak AM, Lechner K, Valent P. Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells.  Am J Hematol. 1999, Vol. 61(1), p66-77.

Wojta J, Kaun C, Breuss JM, Koshelnick Y, Beckmann R, Hattey E, Mildner M, Weninger W, Nakamura T, Tschachler E, Binder BR. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.  Lab Invest, 1999, Vol. 79(4), p427-438.

Zhang JC, Ruan Q, Paucz L, Fabry A, Binder BR, Wojta J. Stimulation of tissue factor expression in human microvascular and macrovascular endothelial cells by cultured vascular smooth muscle cells in vitro.  J Vasc Res, 1999, Vol. 36(2), p126-132.

Zoellner H, Hou JY, Lovery M, Kingham J, Srivastava M, Bielek E, Vanyek E, Binder BR. Inhibition of microvascular endothelial apoptosis in tissue explants by serum albumin.  Microvasc Res. 1999, Vol. 57(2), p162-173.